News

Technology News

Onset Medical Receives SoloPath CE Mark

Wednesday, April 16, 2008 5:17:00 AM PDT | VentureDeal staff

IRVINE, CA -- Medical device company Onset Medical announced that it has received CE Mark Clearance to begin marketing its SoloPath Catheter in the European Union and select countries worldwide.

SoloPath is a percutaneous transseptal access catheter based on the company's Controlled Deployment Technology (CDT).  The platform allows the "introduction of a dimensionally small catheter to a specific site, which once positioned, can be radially expanded to deploy a semi-rigid sheath to maintain access to the treatment site."

The SoloPath technology allows cardiologists  a novel approach to access the left atrium and pulmonary veins through the atrial septum, for treatment of such conditions as atrial fibrillation.

Email Page  Email Page | Print Page Print Page

Loading

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.